KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Change in Taxes (2016 - 2021)

Historic Change in Taxes for BeOne Medicines (ONC) over the last 6 years, with Q1 2021 value amounting to $7.1 million.

  • BeOne Medicines' Change in Taxes rose 1758.22% to $7.1 million in Q1 2021 from the same period last year, while for Mar 2021 it was $3.4 million, marking a year-over-year decrease of 7327.44%. This contributed to the annual value of $2.3 million for FY2020, which is 6934.97% down from last year.
  • Per BeOne Medicines' latest filing, its Change in Taxes stood at $7.1 million for Q1 2021, which was up 1758.22% from $14.6 million recorded in Q4 2020.
  • BeOne Medicines' Change in Taxes' 5-year high stood at $14.6 million during Q4 2020, with a 5-year trough of -$9.3 million in Q3 2020.
  • Its 5-year average for Change in Taxes is $1.2 million, with a median of $969000.0 in 2019.
  • As far as peak fluctuations go, BeOne Medicines' Change in Taxes surged by 525151.52% in 2017, and later tumbled by 173022.39% in 2018.
  • Over the past 5 years, BeOne Medicines' Change in Taxes (Quarter) stood at $6.3 million in 2017, then plummeted by 32.55% to $4.3 million in 2018, then grew by 3.32% to $4.4 million in 2019, then surged by 232.14% to $14.6 million in 2020, then crashed by 51.0% to $7.1 million in 2021.
  • Its last three reported values are $7.1 million in Q1 2021, $14.6 million for Q4 2020, and -$9.3 million during Q3 2020.